Following the FDA ODD, European designation underscores ICT01’s potential as a novel immunotherapy approach in AML ...

Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...

ImCheck’s ICT01 Receives FDA Orphan Drug Designation Clinical data showing unprecedented remission rates in newly diagnosed ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

US$450 million project loan facility secured from new strategic partner Appian Capital Advisory to fund the development and ...